DR. HOWARD H SUSSMAN, MD
Medical Practice at Pasteur Dr, Palo Alto, CA
License number
California G21284
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-6073
(650) 724-6902 (Fax)
(650) 724-6902 (Fax)
Professional information
Howard H Sussman, Palo Alto CA
Specialties:
Pathology, Clinical Pathology/Laboratory Medicine, Anatomic Pathology & Clinical Pathology, Neuropathology
Work:
Stanford University Hosp
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
Oregon Health & Science University (1960)
Dr. Howard H Sussman, Stanford CA - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
300 Pasteur Dr STE H2110, Stanford 94305
(650) 723-6073 (Phone), (650) 725-6902 (Fax)
(650) 723-6073 (Phone), (650) 725-6902 (Fax)
Languages:
English, Spanish
Hospitals:
300 Pasteur Dr STE H2110, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Oregon Health Sciences University
Graduated: 1960
Oregon Health Sciences University
Graduated: 1960
Regulated Genes In Cervical Cancer
US Patent:
2006015, Jul 13, 2006
Filed:
Dec 2, 2005
Appl. No.:
11/293598
Inventors:
Gregory Sgarlato - Stanford CA, US
Catharine Eastman - Palo Alto CA, US
Howard Sussman - Stanford CA, US
Catharine Eastman - Palo Alto CA, US
Howard Sussman - Stanford CA, US
International Classification:
C12Q 1/68, G01N 33/574, C12P 19/34
US Classification:
435006000, 435007230, 435091200
Abstract:
Polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in SCCC cells are provided. The polynucleotides find use in diagnosis of cancer, and classification of cancer cells according to expression profiles. The methods are useful for detecting cervical cancer cells, facilitating diagnosis of cervical cancer and the severity of the cancer (e.g., tumor grade, tumor burden, and the like) in a subject, facilitating a determination of the prognosis of a subject, and assessing the responsiveness of the subject to therapy.